NCAM1 and telomere syndrome: To test this, we analyzed CD3+ and/or CD56+ lymphocytes in a subset of patients from the previous cohort using multiparametric flow cytometry, and applied AI-assisted unsupervised clustering to comprehensively map the systemic cytotoxic immune landscape in STS.